Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapyMelody Smith, Marco Ruella, Guido Ghilardi et al.|Nature Medicine|2022Cited by 308
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapyGuido Ghilardi, Marco Ruella, Joseph A. Fraietta et al.|Nature Medicine|2024Cited by 254
Bendamustine is safe and effective for lymphodepletion before tisagenlecleucel in patients with refractory or relapsed large B-cell lymphomasGuido Ghilardi, Stephen J. Schuster, Elise A. Chong et al.|Annals of Oncology|2022Cited by 95
High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection in Allogeneic Stem-Cell Transplantation With Reduced-Intensity ConditioningRan Reshef, David Porter, Austin P. Huffman et al.|Journal of Clinical Oncology|2015Cited by 60
Bendamustine lymphodepletion before axicabtagene ciloleucel is safe and associates with reduced inflammatory cytokinesGuido Ghilardi, Marco Ruella, Luca Paruzzo et al.|Blood Advances|2023Cited by 30